David Raubach

Lung Cancer Awareness Through a Pandemic

Oklahoma Proton Center Offering Free Lung Screening for High-Risk Individuals in November Lung cancer is the 2nd most common cancer amongst men and women in the United States and is by far the leading cause of cancer-related death. “It’s a difficult disease, with potentially difficult outcomes,” says David Raubach, Chief Development Officer at Oklahoma Proton […]

Read More

Proton Therapy Safer Than Conventional Radiation Treatment Per Stanford Study

Proton Therapy reduces the risk of a second cancer diagnosis by 69% versus other forms of radiation treatment according to a paper recently released by a team from Stanford University. The study looked at 450,373 patients in the National Cancer Database who received either 3D conformal radiation therapy (3DCRT), Intensity Modulated Radiation Therapy (IMRT), or […]

Read More
en English
X